Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1138685

	registered interest
	date	12/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	IVF
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the (a) financial, (b) emotional and (c) medical implications for couples experiencing infertility problems of IVF services being decommissioned by clinical commissioning groups.
	tabling member constituency	Coventry North East
	tabling member printed	Colleen Fletcher
	uin	276551
	answer	answer is ministerial correction date of answer 16/07/2019 answer text <p>Infertility is recognised as a disease by all mainstream international health organisations. In the United Kingdom, infertility affects one in seven of all couples of child-bearing age. It can cause great psychological distress for those seeking to start a family, if not addressed. There are effective treatments and the National Institute for Health and Care Excellence (NICE) Fertility Guidelines set out clearly how the treatment can be offered in the most clinically and cost-effective way. The Government recognises that there is variation in the commissioning of National Health Service fertility services across England. Patients with infertility have every right to expect NHS services based on clinical need.</p><p> </p><p>Clinical commissioning groups (CCGs) have a statutory responsibility to commission healthcare services that meet the needs of their whole population, including fertility services. The Human Fertilisation and Embryology Authority’s guidance for commissioners is a new tool to help them implement NICE Fertility Guidelines and use the benchmark price treatments.</p><p> </p><p>I wrote to the Chief Executives of all CCGs in England on 17 June 2019 to promote the guidance and benchmark price, and strongly encourage them to implement fully the NICE Fertility Guidelines.</p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 276552 276556 question first answered 16/07/2019 14:53:34 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	4378 label Biography information for Colleen Fletcher

1138686

	registered interest
	date	12/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	IVF
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent steps his Department has take to ensure equity of access to IVF treatment throughout England.
	tabling member constituency	Coventry North East
	tabling member printed	Colleen Fletcher
	uin	276552
	answer	answer is ministerial correction date of answer 16/07/2019 answer text <p>Infertility is recognised as a disease by all mainstream international health organisations. In the United Kingdom, infertility affects one in seven of all couples of child-bearing age. It can cause great psychological distress for those seeking to start a family, if not addressed. There are effective treatments and the National Institute for Health and Care Excellence (NICE) Fertility Guidelines set out clearly how the treatment can be offered in the most clinically and cost-effective way. The Government recognises that there is variation in the commissioning of National Health Service fertility services across England. Patients with infertility have every right to expect NHS services based on clinical need.</p><p> </p><p>Clinical commissioning groups (CCGs) have a statutory responsibility to commission healthcare services that meet the needs of their whole population, including fertility services. The Human Fertilisation and Embryology Authority’s guidance for commissioners is a new tool to help them implement NICE Fertility Guidelines and use the benchmark price treatments.</p><p> </p><p>I wrote to the Chief Executives of all CCGs in England on 17 June 2019 to promote the guidance and benchmark price, and strongly encourage them to implement fully the NICE Fertility Guidelines.</p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 276551 276556 question first answered 16/07/2019 14:53:34 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	4378 label Biography information for Colleen Fletcher

1138691

	registered interest
	date	12/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	IVF
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department has taken to prevent clinical commissioning groups from decommissioning IVF services.
	tabling member constituency	Coventry North East
	tabling member printed	Colleen Fletcher
	uin	276556
	answer	answer is ministerial correction date of answer 16/07/2019 answer text <p>Infertility is recognised as a disease by all mainstream international health organisations. In the United Kingdom, infertility affects one in seven of all couples of child-bearing age. It can cause great psychological distress for those seeking to start a family, if not addressed. There are effective treatments and the National Institute for Health and Care Excellence (NICE) Fertility Guidelines set out clearly how the treatment can be offered in the most clinically and cost-effective way. The Government recognises that there is variation in the commissioning of National Health Service fertility services across England. Patients with infertility have every right to expect NHS services based on clinical need.</p><p> </p><p>Clinical commissioning groups (CCGs) have a statutory responsibility to commission healthcare services that meet the needs of their whole population, including fertility services. The Human Fertilisation and Embryology Authority’s guidance for commissioners is a new tool to help them implement NICE Fertility Guidelines and use the benchmark price treatments.</p><p> </p><p>I wrote to the Chief Executives of all CCGs in England on 17 June 2019 to promote the guidance and benchmark price, and strongly encourage them to implement fully the NICE Fertility Guidelines.</p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 276551 276552 question first answered 16/07/2019 14:53:34 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	4378 label Biography information for Colleen Fletcher

1131710

	registered interest
	date	12/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Haematological Cancer: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many people who have been diagnosed with blood cancer were offered a holistic needs assessment in (a) 2016, (b) 2017 and (c) 2018.
	tabling member constituency	Coventry North East
	tabling member printed	Colleen Fletcher
	uin	263851
	answer	answer is ministerial correction date of answer 17/06/2019 answer text <p>Data is currently being analysed on the number of Holistic Needs Assessments (HNAs) being recorded by National Health Service trusts. This data only became required from April 2018 as part of the Public Health England Cancer Outcomes and Services Dataset therefore figures from before this date will be incomplete. A baseline survey of NHS trusts for January to March 2017 indicated that around 30% of blood cancer patients are offered an HNA. Since then, Cancer Alliances have been rolling out HNA along with other personalised care interventions, therefore it is expected that this figure will now be higher.</p><p> </p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 17/06/2019 15:33:40 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4378 label Biography information for Colleen Fletcher

1131714

	registered interest
	date	12/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what is routinely offered to patients as part of the holistic needs assessment to help provide emotional and psychological support during and after a cancer diagnosis and treatment.
	tabling member constituency	Coventry North East
	tabling member printed	Colleen Fletcher
	uin	263855
	answer	answer is ministerial correction date of answer 17/06/2019 answer text <p>When a person has a Holistic Needs Assessments (HNA) they are asked to identify any concerns from a checklist which will normally include emotional, relationship and spiritual concerns. People can of course, raise concerns at any time with their general practitioner or hospital team, not just when an HNA is being done. This should lead to actions being agreed in a personalised care and support plan that includes appropriate action to support the person with their psychosocial or mental health needs. For example:</p><p>- Signposting a person to peer support or cancer ‘buddies’ through patient groups, online forums etc;</p><p>- Signposting a person to a cancer support centre such as Maggie’s or a Macmillan Information centre;</p><p>- Providing training in relaxation techniques, problem solving and coping strategies;</p><p>- Referring a person to professional support in the form of emotional and basic psychological support from a clinical nurse specialist, or counselling from a trained professional such as a clinical psychologist; and</p><p>- Referring a person to professional support in the form of services for more serious mental health needs.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 17/06/2019 15:23:12 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4378 label Biography information for Colleen Fletcher

1131717

	registered interest
	date	12/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Children and Young People
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many times on average children and young people have seen their GP before being diagnosed with (a) cancer and (b) blood cancer in each of the last five years.
	tabling member constituency	Coventry North East
	tabling member printed	Colleen Fletcher
	uin	263858
	answer	answer is ministerial correction date of answer 17/06/2019 answer text <p>The information requested is not held centrally.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 263859 question first answered 17/06/2019 15:21:46 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4378 label Biography information for Colleen Fletcher

1131718

	registered interest
	date	12/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Children and Young People
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the average stage is of (a) cancer and (b) blood cancer diagnosed in children and young people.
	tabling member constituency	Coventry North East
	tabling member printed	Colleen Fletcher
	uin	263859
	answer	answer is ministerial correction date of answer 17/06/2019 answer text <p>The information requested is not held centrally.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 263858 question first answered 17/06/2019 15:21:46 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4378 label Biography information for Colleen Fletcher

1078523

	registered interest
	date	27/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cervical Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether he plans to extend routine cervical screening to women aged 65 and over.
	tabling member constituency	Coventry North East
	tabling member printed	Colleen Fletcher
	uin	226680
	answer	answer is ministerial correction date of answer 04/03/2019 answer text <p>The National Health Service Cervical Screening Programme currently stops sending invitations for cervical screening after a woman reaches 65, unless they need ongoing surveillance or follow up. This is generally required if a woman has had an abnormal result in any of her three most recent tests or is recommended for early repeats owing to a previous abnormality.</p><p> </p><p>The natural history of cervical cancer means that it is unlikely that women of 65 and over who have been regularly screened and discharged from the programme will go on to develop the disease. We also know that screening becomes more uncomfortable after menopause.</p><p> </p><p>The United Kingdom National Screening Committee (UK NSC) recently reviewed a proposal about the care of women aged 64 exiting the programme. The outcome of this proposal will be published in the UK NSC’s minutes which will be available in six weeks at the following link:</p><p><a href="https://www.gov.uk/government/groups/uk-national-screening-committee-uk-nsc" target="_blank">https://www.gov.uk/government/groups/uk-national-screening-committee-uk-nsc</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 04/03/2019 17:00:29 answering member 4067 label Biography information for Steve Brine
	tabling member	4378 label Biography information for Colleen Fletcher

1015146

	registered interest
	date	26/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Transplant Surgery
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with Cabinet colleagues on the effect of the UK leaving the EU on the transportation of donated (a) stem cells, (b) blood and (c) organs to the UK from countries within the EU.
	tabling member constituency	Coventry North East
	tabling member printed	Colleen Fletcher
	uin	195656
	answer	answer is ministerial correction date of answer 29/11/2018 answer text <p>The Secretary of State discusses a range of issues with Cabinet colleagues. Patient safety is paramount in the Government’s exit negotiations and maintaining continuity of supply of stem cells, blood and organs is a key part of ensuring patients continue to receive the safe high-quality care they need on day one of European Union exit and thereafter.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 29/11/2018 17:34:17 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	4378 label Biography information for Colleen Fletcher

997809

	registered interest
	date	30/10/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Haematological Cancer: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what progress has been made on preparing hospitals in England to deliver CAR-T cell therapies for patients with blood cancer.
	tabling member constituency	Coventry North East
	tabling member printed	Colleen Fletcher
	uin	185617
	answer	answer is ministerial correction date of answer 05/11/2018 answer text <p>NHS England is working with the manufacturers and NHS providers to prepare the National Health Service to begin delivering Chimeric Antigen Receptor T Cell (CAR-T) therapy - the first in a wave of treatments in a new era of personalised medicine and part of the NHS’s long-term plan to upgrade cancer service. The first treatment that will be available to patient is tisagenlecleucel (Kymriah) as an option for treating children and young people up to 25 years old with B cell acute lymphoblastic leukaemia that is refractory, in relapsed post-transplant or in second or later relapse.</p><p> </p><p>NHS England anticipates that the National Institute for Health and Care Excellence will recommend this treatment for entry into the Cancer Drugs Fund in mid-November. If so, funding will be made immediately available, following a successful commercial deal with the manufacturer Novartis. We anticipate the first patients will begin their treatment in late November 2018. The phased implementation required by the manufacturer and the NHS means that full capacity to treat eligible patients will take some months to achieve and a National CAR-T Clinical Panel will convene in mid-November to assure equity of access and prioritise eligible patients.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/11/2018 11:11:35 answering member 4067 label Biography information for Steve Brine
	tabling member	4378 label Biography information for Colleen Fletcher